Signal Transducer and Activator of Transcription 3 (STAT3)
Signal Transducer and Activator of Transcription 3 (STAT3) is a multifunctional transcription factor that serves as a central node in numerous cytokine and growth factor signaling cascades.
Signal Transducer and Activator of Transcription 3 (STAT3) is a multifunctional transcription factor that serves as a central node in numerous cytokine and growth factor signaling cascades. Upon activation — most characteristically via phosphorylation at Tyrosine 705 (Tyr705) by upstream kinases such as JAKs — STAT3 dimerizes, translocates to the nucleus, and drives transcription of genes governing cell survival, proliferation, differentiation, and immune modulation. Physiologically, STAT3 is activated downstream of cytokines such as Interleukin-6 (IL-6) and growth factors including Insulin-like growth factor 1 (IGF-1), making it a critical regulator of tissue homeostasis and inflammation. Its activity is tightly coupled to co-regulatory networks involving pathways such as Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB) and HIF-1α, underscoring its role as an integrative signal hub.
In disease contexts, STAT3 is one of the most extensively studied oncogenic transcription factors. Aberrant or sustained STAT3 activation has been documented across a broad range of malignancies — including breast cancer, bladder cancer, and hepatic metastatic disease — where it shapes both tumor cell behavior and the surrounding tumor microenvironment. Beyond oncology, STAT3 has emerged as a regulator in fibrotic diseases and in the biology of aging skeletal muscle, reflecting its broad pathophysiological relevance and its attractiveness as a therapeutic target.
Where the papers sit
48 papers from the last 6 months study Signal Transducer and Activator of Transcription 3 (STAT3) directly · updated from PubMed 14 Nov 2026
Study type 0 clinical trials · 1 observational · 1 human data · 46 preclinical
Themes one subject · 1 paradigm shift
Those 48 are all about one subject.
-
STAT3-Linked Disease Biology
STAT3-linked signaling remains a broad disease-biology and therapeutic target rather than a single translational program. Studies connect it to ferroptosis, immune resistance, metabolism, inflammation, tissue repair, and neuronal injury across cancers and noncancer diseases. Recurrent mechanisms include GPX4/SLC40A1, c-Met, IL-6, PD-L1/PDK4/GLS, NF-κB/NFATc1, and FOXO1 pathways. The shared agenda is to find selective STAT3 modulators or delivery strategies, but the cluster shows no unified clinical direction.
STAT3 blockade can drive ferroptosis rather than primarily apoptotic cancer-cell death
In colorectal cancer treated with the STAT3-binding curcumin analogue FLLL32 and ovarian cancer treated with atranorin, the studies found that suppressing STAT3 signaling produced ferroptotic death, with iron accumulation, lipid peroxidation, or ferroptosis-associated molecular changes outweighing conventional apoptosis as the operative mechanism. This contrasts with the set’s predominant model of STAT3 inhibition as an antiproliferative or pro-apoptotic intervention and redirects therapeutic evaluation toward ferroptosis control and susceptibility markers. 42900324Oct 42496762Jul
Papers
The 48 papers from the last 6 months that study Signal Transducer and Activator of Transcription 3 (STAT3) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
STAT3-Linked Disease Biology (48)
- Curcumin analogue FLLL32 induces ferroptosis by targeting the STAT3-GPX4/SLC40A1 axis in colorectal cancer. Molecular biomedicine · 20 Oct 2026 PMID 42900324
- Engineered mesenchymal stem cell-derived small extracellular vesicles delivering miR-124 suppress colorectal cancer progression through EZH2 downregulation and attenuation of STAT3 signaling. Medical oncology (Northwood, London, England) · 8 Oct 2026 PMID 42848258
- Thieno[2,3-d]pyrimidine scaffold optimization for synergistic c-Met/STAT3 blockade: Synthesis, structure-activity relationships, in vitro potency, and apoptotic pathways in colorectal cancer. Bioorganic chemistry · 21 Sept 2026 PMID 42767173
- A trimethyl lock successfully stabilizes a nascent Michael acceptor for prodrug applications. Chemical communications (Cambridge, England) · 21 Sept 2026 PMID 42766013
- SAT1 promotes prostate cancer progression and decreases enzalutamide sensitivity by enhancing spermine catabolism. Human cell · 16 Sept 2026 PMID 42744967
- STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma. Oncoimmunology · 15 Sept 2026 PMID 42740603
- Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1. Science advances · 11 Sept 2026 PMID 42726875
- Amniotic fluid stem cells alleviate neuronal injury-related changes in spina bifida by inducing autophagy via regulating the FOXO1/STAT3 axis. Organogenesis · 11 Sept 2026 PMID 42723550
- Identification of STAT1 as a biomarker for lymph node metastasis in esophageal squamous cell carcinoma. Journal of molecular histology · 5 Sept 2026 PMID 42700277
- Discovery of CDK8/19 inhibitors as lead compounds for IL-6-dependent lymphoma enabled by the formal synthesis of cortistatin A. Science advances · 4 Sept 2026 PMID 42696577
- Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer. Journal for immunotherapy of cancer · 2 Sept 2026 PMID 42686373
- Bruceine D suppressed osteoclast formation via STAT3/NF-κB/NFATc1 signaling and protected postmenopausal osteoporosis. Molecular biology reports · 2 Sept 2026 PMID 42684554
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI. PloS one · 21 Aug 2026 PMID 42627796
- Sinomenine Liposomes Alleviate Neuropathic Pain in a Spared Nerve Injury Model by Regulating Astrocyte Reactivity Associated with Inhibition of the JAK2/STAT3 Pathway. Neurochemical research · 13 Aug 2026 PMID 42593631
- Succinic acid inhibits hepatocyte regenerative signaling via STAT3 SH2-domain engagement. Molecular biomedicine · 7 Aug 2026 PMID 42567937
- CD34 and p16 expression in central nervous system solitary fibrous tumors: an exploratory clinicopathologic study. Journal of neuro-oncology · 6 Aug 2026 PMID 42560553
- Early versus late JAK-STAT-IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation. Science translational medicine · 5 Aug 2026 PMID 42555758
- Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers. Bioorganic chemistry · 4 Aug 2026 PMID 42551351
- Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3/HDAC dual-target inhibitors. Bioorganic chemistry · 29 Jul 2026 PMID 42526131
- Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway. European journal of pharmacology · 27 Jul 2026 PMID 42508712
- Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and biophysical research communications · 24 Jul 2026 PMID 42497831
- Targeting Cys328 in the STAT3 DNA-binding domain with the germacrane-type sesquiterpene lactone SCP-7 inhibits colorectal Cancer growth in vitro and in vivo. Bioorganic chemistry · 24 Jul 2026 PMID 42497765
- Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 24 Jul 2026 PMID 42497519
- Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer. Molecular biology reports · 24 Jul 2026 PMID 42496762
- Discovery of SH-17 as a pioneering STAT3/HDAC bifunctional inhibitor that simultaneously impairs Tyr705 and Ser727 phosphorylation. Bioorganic chemistry · 21 Jul 2026 PMID 42480231
- Effects of stattic and vinblastine on apoptosis and fatty acid profile in A549 lung cancer cells. Molecular biology reports · 20 Jul 2026 PMID 42474554
- FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance. Cell metabolism · 16 Jul 2026 PMID 42462724
- A template-defined TA-Fe nanoplatform enables mechanistic decoupling and lysosome-gated immunomodulation for diabetic wound healing. Journal of materials chemistry. B · 13 Jul 2026 PMID 42438451
- Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular biology reports · 8 Jul 2026 PMID 42417926
- Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration. Journal of medicinal chemistry · 5 Jul 2026 PMID 42402082
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis. In vivo (Athens, Greece) · 30 Jun 2026 PMID 42379744
- SLC5A2-SRC-ERK/STAT3 signaling network in proximal tubule S1 cells mediates the renoprotective effects of dapagliflozin in obese mice. Biochemical and biophysical research communications · 27 Jun 2026 PMID 42364320
- Discovery of novel NQO1/STAT3/HDAC triple-target agents for the treatment of triple negative breast cancer. Bioorganic chemistry · 24 Jun 2026 PMID 42341572
- Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell · 22 Jun 2026 PMID 42330950
- Design, synthesis, bio-evaluation, and mechanism of action of novel allosecurinine derivatives as STAT3-based antitumor agents in vitro and in vivo. Bioorganic chemistry · 20 Jun 2026 PMID 42322913
- Design and synthesis of 1-Phenyl-2-thioaryl-4-benzyl-5-methylimidazoles as dual STAT3/NF-κB inhibitors for triple-negative breast Cancer therapy. Bioorganic chemistry · 17 Jun 2026 PMID 42308789
- Design, synthesis, and biological evaluation of clovamide analogues as anti-colitis agents modulating NF-κB/STAT3/iNOS signaling. Bioorganic chemistry · 17 Jun 2026 PMID 42308787
- Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure. Bioorganic chemistry · 17 Jun 2026 PMID 42308786
- BP-1-102 inhibits multiple pathways of NFATc1 activation to alleviate osteoporosis and downregulate osteoclast differentiation in ovariectomized mice. Biochemical and biophysical research communications · 17 Jun 2026 PMID 42308767
- Type 2 Diabetes Reduces IFN-α2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice. Diabetes · 12 Jun 2026 PMID 42283639
- Extracellular vesicle-encapsulated miRNAs mediate monocyte-endothelial cell crosstalk to exacerbate renal injury in diabetic kidney disease. International immunopharmacology · 11 Jun 2026 PMID 42275918
- Network pharmacology and experimental validation reveal inhibition of the JAK2/STAT3 pathway by hydrogen sulfide in diabetic cardiomyopathy. International immunopharmacology · 8 Jun 2026 PMID 42259239
- Artesunate attenuates sepsis-induced myocardial injury: A preliminary investigation into the JAK2/STAT3 pathway via integrated network pharmacology and experimental validation. Biochemical and biophysical research communications · 4 Jun 2026 PMID 42241977
- Spatiotemporal atlas of pro-inflammatory NF-κB and anti-inflammatory STAT6 signaling using reporter mice during mRNA vaccination. Molecular therapy : the journal of the American Society of Gene Therapy · 3 Jun 2026 PMID 42231579
- Guanxin Ⅱ alleviates atherosclerotic comorbid depression via modulating AKT1-STAT3-TLR4 axis and ATG3-mediated autophagy. Journal of ethnopharmacology · 20 May 2026 PMID 42162760
- Chinese authentic herbal medicine Ganhuangcao from Southwest China mitigates influenza virus infection by inhibiting the host JAK2/STAT1 signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 20 May 2026 PMID 42160896
By study type
Observational studies and case reports (1)
- CD34 and p16 expression in central nervous system solitary fibrous tumors: an exploratory clinicopathologic study. Journal of neuro-oncology · 6 Aug 2026 PMID 42560553
Human data, design not indexed (1)
- A trimethyl lock successfully stabilizes a nascent Michael acceptor for prodrug applications. Chemical communications (Cambridge, England) · 21 Sept 2026 PMID 42766013
Preclinical: animal, cell and lab studies (46)
- Curcumin analogue FLLL32 induces ferroptosis by targeting the STAT3-GPX4/SLC40A1 axis in colorectal cancer. Molecular biomedicine · 20 Oct 2026 PMID 42900324
- Engineered mesenchymal stem cell-derived small extracellular vesicles delivering miR-124 suppress colorectal cancer progression through EZH2 downregulation and attenuation of STAT3 signaling. Medical oncology (Northwood, London, England) · 8 Oct 2026 PMID 42848258
- Thieno[2,3-d]pyrimidine scaffold optimization for synergistic c-Met/STAT3 blockade: Synthesis, structure-activity relationships, in vitro potency, and apoptotic pathways in colorectal cancer. Bioorganic chemistry · 21 Sept 2026 PMID 42767173
- SAT1 promotes prostate cancer progression and decreases enzalutamide sensitivity by enhancing spermine catabolism. Human cell · 16 Sept 2026 PMID 42744967
- STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma. Oncoimmunology · 15 Sept 2026 PMID 42740603
- Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1. Science advances · 11 Sept 2026 PMID 42726875
- Amniotic fluid stem cells alleviate neuronal injury-related changes in spina bifida by inducing autophagy via regulating the FOXO1/STAT3 axis. Organogenesis · 11 Sept 2026 PMID 42723550
- Identification of STAT1 as a biomarker for lymph node metastasis in esophageal squamous cell carcinoma. Journal of molecular histology · 5 Sept 2026 PMID 42700277
- Discovery of CDK8/19 inhibitors as lead compounds for IL-6-dependent lymphoma enabled by the formal synthesis of cortistatin A. Science advances · 4 Sept 2026 PMID 42696577
- Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer. Journal for immunotherapy of cancer · 2 Sept 2026 PMID 42686373
- Bruceine D suppressed osteoclast formation via STAT3/NF-κB/NFATc1 signaling and protected postmenopausal osteoporosis. Molecular biology reports · 2 Sept 2026 PMID 42684554
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI. PloS one · 21 Aug 2026 PMID 42627796
- Sinomenine Liposomes Alleviate Neuropathic Pain in a Spared Nerve Injury Model by Regulating Astrocyte Reactivity Associated with Inhibition of the JAK2/STAT3 Pathway. Neurochemical research · 13 Aug 2026 PMID 42593631
- Succinic acid inhibits hepatocyte regenerative signaling via STAT3 SH2-domain engagement. Molecular biomedicine · 7 Aug 2026 PMID 42567937
- Early versus late JAK-STAT-IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation. Science translational medicine · 5 Aug 2026 PMID 42555758
- Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers. Bioorganic chemistry · 4 Aug 2026 PMID 42551351
- Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3/HDAC dual-target inhibitors. Bioorganic chemistry · 29 Jul 2026 PMID 42526131
- Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway. European journal of pharmacology · 27 Jul 2026 PMID 42508712
- Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and biophysical research communications · 24 Jul 2026 PMID 42497831
- Targeting Cys328 in the STAT3 DNA-binding domain with the germacrane-type sesquiterpene lactone SCP-7 inhibits colorectal Cancer growth in vitro and in vivo. Bioorganic chemistry · 24 Jul 2026 PMID 42497765
- Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 24 Jul 2026 PMID 42497519
- Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer. Molecular biology reports · 24 Jul 2026 PMID 42496762
- Discovery of SH-17 as a pioneering STAT3/HDAC bifunctional inhibitor that simultaneously impairs Tyr705 and Ser727 phosphorylation. Bioorganic chemistry · 21 Jul 2026 PMID 42480231
- Effects of stattic and vinblastine on apoptosis and fatty acid profile in A549 lung cancer cells. Molecular biology reports · 20 Jul 2026 PMID 42474554
- FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance. Cell metabolism · 16 Jul 2026 PMID 42462724
- A template-defined TA-Fe nanoplatform enables mechanistic decoupling and lysosome-gated immunomodulation for diabetic wound healing. Journal of materials chemistry. B · 13 Jul 2026 PMID 42438451
- Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular biology reports · 8 Jul 2026 PMID 42417926
- Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration. Journal of medicinal chemistry · 5 Jul 2026 PMID 42402082
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis. In vivo (Athens, Greece) · 30 Jun 2026 PMID 42379744
- SLC5A2-SRC-ERK/STAT3 signaling network in proximal tubule S1 cells mediates the renoprotective effects of dapagliflozin in obese mice. Biochemical and biophysical research communications · 27 Jun 2026 PMID 42364320
- Discovery of novel NQO1/STAT3/HDAC triple-target agents for the treatment of triple negative breast cancer. Bioorganic chemistry · 24 Jun 2026 PMID 42341572
- Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell · 22 Jun 2026 PMID 42330950
- Design, synthesis, bio-evaluation, and mechanism of action of novel allosecurinine derivatives as STAT3-based antitumor agents in vitro and in vivo. Bioorganic chemistry · 20 Jun 2026 PMID 42322913
- Design and synthesis of 1-Phenyl-2-thioaryl-4-benzyl-5-methylimidazoles as dual STAT3/NF-κB inhibitors for triple-negative breast Cancer therapy. Bioorganic chemistry · 17 Jun 2026 PMID 42308789
- Design, synthesis, and biological evaluation of clovamide analogues as anti-colitis agents modulating NF-κB/STAT3/iNOS signaling. Bioorganic chemistry · 17 Jun 2026 PMID 42308787
- Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure. Bioorganic chemistry · 17 Jun 2026 PMID 42308786
- BP-1-102 inhibits multiple pathways of NFATc1 activation to alleviate osteoporosis and downregulate osteoclast differentiation in ovariectomized mice. Biochemical and biophysical research communications · 17 Jun 2026 PMID 42308767
- Type 2 Diabetes Reduces IFN-α2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice. Diabetes · 12 Jun 2026 PMID 42283639
- Extracellular vesicle-encapsulated miRNAs mediate monocyte-endothelial cell crosstalk to exacerbate renal injury in diabetic kidney disease. International immunopharmacology · 11 Jun 2026 PMID 42275918
- Network pharmacology and experimental validation reveal inhibition of the JAK2/STAT3 pathway by hydrogen sulfide in diabetic cardiomyopathy. International immunopharmacology · 8 Jun 2026 PMID 42259239
- Artesunate attenuates sepsis-induced myocardial injury: A preliminary investigation into the JAK2/STAT3 pathway via integrated network pharmacology and experimental validation. Biochemical and biophysical research communications · 4 Jun 2026 PMID 42241977
- Spatiotemporal atlas of pro-inflammatory NF-κB and anti-inflammatory STAT6 signaling using reporter mice during mRNA vaccination. Molecular therapy : the journal of the American Society of Gene Therapy · 3 Jun 2026 PMID 42231579
- Guanxin Ⅱ alleviates atherosclerotic comorbid depression via modulating AKT1-STAT3-TLR4 axis and ATG3-mediated autophagy. Journal of ethnopharmacology · 20 May 2026 PMID 42162760
- Chinese authentic herbal medicine Ganhuangcao from Southwest China mitigates influenza virus infection by inhibiting the host JAK2/STAT1 signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 20 May 2026 PMID 42160896
Written from 48 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.